“A definitive 53-week study was conducted in 27 horses (Study # GENZ-09-4417)”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Pivotal GLP studies
Combined GLP-type pharm/tox 53-week equine study (27 horses, stifle trochlear defect implant); 12- and 24-week rabbit studies
“A definitive 53-week study was conducted in 27 horses (Study # GENZ-09-4417) to evaluate the safety and the activity of MACI”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Route in tox
Surgical implantation into cartilage defect (intra-articular, fibrin sealant fixed)
“Implantation is performed using sterile surgical techniques and requires both the preparation of the defect bed and the application of fibrin sealant”
✓ VerifiedFDA pharmacology/toxicology review, p. 3Source ↗